Dry eye syndrome affects millions of people globally, but its cause is often a complex "puzzle" of environmental and physiological factors. Automated Tear Film Analysis, powered by deep learning, is finally providing the clarity needed for effective treatment.
Using high-resolution meibography, AI algorithms can automatically detect meibomian gland drop-out and grade the severity of ocular surface disease with a level of standardization that was previously impossible. This quantitative approach ensures that every R2 Trading AI user gets a truly personalized management plan.
Standardizing Care
The goal is to eliminate subjectivity. Whether it's analyzing the tear break-up time (TBUT) or the lipid layer thickness, our AI systems provide a consistent baseline to measure the true effectiveness of your vision solution over time.
